SCHEMBL26857005

SCHEMBL26857005

CN1CCO[C@H](CNC(=O)c2cc(-c3ccc4nc(N)nn4c3)cs2)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACKR3 P25106 2/20 0.42
▸ MMP12 P39900 5/20 0.40
▸ PIK3CA P42336 1/20 0.39
▸ PIK3CG P48736 1/20 0.39
▸ EGLN1 Q9GZT9 3/20 0.38
▸ MMP2 P08253 1/20 0.38
▸ MMP8 P22894 1/20 0.38
▸ MMP13 P45452 1/20 0.38
▸ MAPK1 P28482 3/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ TTK P33981 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ WNT1 P04628 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ NTRK1 P04629 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26856936 0.86 HPGD (0.47) MAPK1KDM4EALDH1A1PKMHPGD
SCHEMBL26856995 0.86 MMP12 (0.40) MMP12PIK3CAPIK3CGMMP2MMP8
SCHEMBL26856993 0.86 HPGD (0.44) MMP12PIK3CAPIK3CGMAPK1KDM4E
SCHEMBL26857060 0.85 TTK (0.45) MMP12PIK3CAPIK3CGTTKGSK3B
SCHEMBL26856933 0.83 PIK3CA (0.46) MMP12PIK3CAPIK3CGMMP2MMP8
SCHEMBL26856997 0.82 MAPK8 (0.44) MMP12PIK3CAPIK3CGMMP2MMP8
SCHEMBL26856937 0.82 PIK3CG (0.48) MMP12PIK3CAPIK3CGMAPK1TTK
SCHEMBL26856930 0.81 PIK3CG (0.47) MMP12PIK3CAPIK3CGMAPK1TTK
SCHEMBL26856958 0.81 PIK3CA (0.42) MMP12PIK3CAPIK3CGMMP2MMP8
SCHEMBL26857148 0.79 MARK3 (0.46) MMP12PIK3CAPIK3CGTTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-30 — — US disclosed
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF SNCA, PSEN2, PARK7 ACKR3 4870/4885MMP12 4866/4885PIK3CA 841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback